Article

High Prevalence of Gonococcal and Chlamydial Infection in Men Who Have Sex With Men With Newly Diagnosed HIV Infection: An Opportunity for Same-Day Presumptive Treatment

San Francisco Department of Public Health Sexually Transmitted Disease Control and Prevention Services San Francisco, CA, USA.
JAIDS Journal of Acquired Immune Deficiency Syndromes (Impact Factor: 4.39). 06/2008; 48(1):109-12. DOI: 10.1097/QAI.0b013e318165dc0b
Source: PubMed

ABSTRACT The increasing use of point-of-care HIV tests in sexually transmitted disease (STD) clinics allows for rapid identification of patients with newly diagnosed HIV infection who may also be at risk for more common sexually transmitted infections. Positive point-of-care HIV test results might be used to identify and provide presumptive treatment to patients who are likely to be coinfected with gonorrhea (GC) and chlamydia (CT).
Data from 6864 STD clinic visits by men who have sex with men (MSM) with no history of HIV infection and an HIV antibody test at that visit were analyzed. Results from rectal, pharyngeal, and urine nucleic acid amplification tests were used to calculate the prevalence of infection with GC and CT.
MSM with newly diagnosed HIV infection were more likely than HIV-uninfected MSM to be infected with GC (25.9% [53 of 205] vs. 10.9% [728 of 6659]; P < 0.001) and CT (18.5% [38 of 205] vs. 7.8% [518 of 6659]; P < 0.001).
GC and CT are common in MSM with newly diagnosed HIV infection at an STD clinic. In this population, a positive point-of-care HIV test result is a useful risk marker for untreated gonococcal and chlamydial infections and provides a justification for presumptive GC and CT treatment.

Download full-text

Full-text

Available from: Katherine A. Ahrens, Mar 17, 2014
0 Followers
 · 
106 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In Spain, neither the HIV nor the STI national surveillance systems collect information on HIV/STI co-infection. However, there are two networks based on HIV/STI clinics which gather this data. We describe HIV prevalence in men who have sex with men (MSM) diagnosed with infectious syphilis and/or gonorrhoea in 15 STI clinics; and concurrent diagnoses of STI in MSM newly diagnosed with HIV in 19 HIV/STI clinics. In total, 572 MSM were diagnosed with infectious syphilis and 580 with gonorrhoea during 2005-2007. HIV prevalence among syphilis and gonorrhoea cases was 29.8% and 15.2% respectively. In the multivariate analysis, HIV/syphilis co-infection was associated with being Latin American; having a history of STI; reporting exclusively anal intercourse; and having sex with casual or several types of partners. HIV and gonorrhoea co-infection was associated with age older than 45 years; having no education or only primary education completed; and having a history of STI. In total, 1,462 HIV infections were newly diagnosed among MSM during 2003-2007. Of these, 31.0% were diagnosed with other STI at the same time. Factors associated with STI co-infection among new HIV cases in MSM were being Latin American; and having sex with casual partners or with both steady and casual partners. In Spain, a considerable proportion of MSM are co-infected with HIV and STI.
    Eurosurveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 01/2009; 14(48). · 4.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The HIV epidemic in the United States continues to affect racial/ethnic minorities disproportionately and is increasing among men who have sex with men. Late HIV diagnosis remains common. To reduce HIV transmission and facilitate early linkage to care and antiretroviral treatment, the Centers for Disease Control and Prevention recommends universal voluntary HIV screening for all persons ages 13 to 64 years in public and private care settings. Recent studies demonstrate dramatic reductions in morbidity and mortality with widespread use of highly active combination antiretroviral therapy (cART), and some document improved outcomes when cART is initiated with CD4 cell count >/= 350 cells/mm(3). As patients live longer, they are increasingly affected by chronic diseases, notably cardiovascular and renal disease, diabetes, and non-AIDS-defining cancers. Providers should ensure patients undertake preventive lifestyle changes (eg, smoking cessation, exercise, weight loss, dietary modification) and undergo recommended screening tests to reduce their risk for these important comorbidities.
    Current Infectious Disease Reports 02/2009; 11(1):75-83. DOI:10.1007/s11908-009-0011-9
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Commensal lactobacilli that produce hydrogen peroxide (H(2)O(2)) inhibit Neisseria gonorrhoeae in vitro, and clinical data suggest that they are associated with a reduced risk of gonorrhea. We precolonized mice with Lactobacillus crispatus and then challenged them with N. gonorrhoeae, to measure the effects of H(2)O(2)-producing lactobacilli on gonococcal infection. We found no difference in the duration of infection or the number of gonococci recovered from untreated mice and mice colonized with L. crispatus. A gonococcal catalase mutant and a catalase, cytochrome C peroxidase mutant exhibited greater susceptibility to L. crispatus in vitro than did wild-type bacteria; however, recovery of these mutants from mice was not affected by L. crispatus. We also found no evidence that utilization of lactobacillus-produced lactate by N. gonorrhoeae balances the detrimental effects of H(2)O(2) during infection. We conclude that the association between lactobacilli and gonococci is complex and may be subject to factors that have not been reproduced in vitro.
    The Journal of Infectious Diseases 04/2009; 199(9):1369-78. DOI:10.1086/597390 · 5.78 Impact Factor